PERFORMANT HEALTHCARE INC (PHLT) Fundamental Analysis & Valuation

NASDAQ:PHLT • US71377E1055

Current stock price

7.75 USD
+0.02 (+0.26%)
At close:
7.75 USD
0 (0%)
After Hours:

This PHLT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PHLT Profitability Analysis

1.1 Basic Checks

  • In the past year PHLT has reported negative net income.
  • In the past year PHLT had a positive cash flow from operations.
  • In the past 5 years PHLT always reported negative net income.
  • Of the past 5 years PHLT 4 years had a positive operating cash flow.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

  • With a Return On Assets value of -0.80%, PHLT perfoms like the industry average, outperforming 44.55% of the companies in the same industry.
  • PHLT has a Return On Equity of -1.08%. This is comparable to the rest of the industry: PHLT outperforms 53.47% of its industry peers.
  • PHLT has a Return On Invested Capital of 0.19%. This is in the lower half of the industry: PHLT underperforms 60.40% of its industry peers.
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROIC 0.19%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • PHLT has a worse Operating Margin (0.16%) than 60.40% of its industry peers.
  • PHLT does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PHLT Health Analysis

2.1 Basic Checks

  • PHLT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, PHLT has more shares outstanding
  • PHLT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PHLT has a worse debt to assets ratio.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • PHLT has an Altman-Z score of 13.67. This indicates that PHLT is financially healthy and has little risk of bankruptcy at the moment.
  • PHLT has a better Altman-Z score (13.67) than 95.05% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that PHLT is not too dependend on debt financing.
  • PHLT has a Debt to Equity ratio of 0.10. This is in the better half of the industry: PHLT outperforms 77.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 13.67
ROIC/WACC0.02
WACC9.27%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.64 indicates that PHLT has no problem at all paying its short term obligations.
  • PHLT has a better Current ratio (2.64) than 82.18% of its industry peers.
  • PHLT has a Quick Ratio of 2.64. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
  • PHLT has a Quick ratio of 2.64. This is amongst the best in the industry. PHLT outperforms 82.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHLT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.50% over the past year.
  • The Revenue has grown by 15.21% in the past year. This is quite good.
  • PHLT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.95% yearly.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%

3.2 Future

  • Based on estimates for the next years, PHLT will show a very strong growth in Earnings Per Share. The EPS will grow by 50.55% on average per year.
  • Based on estimates for the next years, PHLT will show a quite strong growth in Revenue. The Revenue will grow by 11.37% on average per year.
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. PHLT Valuation Analysis

4.1 Price/Earnings Ratio

  • PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 103.61, PHLT can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, PHLT is valued a bit more expensive than 60.40% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, PHLT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 103.61
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHLT indicates a slightly more expensive valuation: PHLT is more expensive than 62.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 96.91
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • PHLT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PHLT's earnings are expected to grow with 50.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.48%
EPS Next 3Y50.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHLT Dividend Analysis

5.1 Amount

  • No dividends for PHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PHLT Fundamentals: All Metrics, Ratios and Statistics

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (10/20/2025, 8:10:13 PM)

After market: 7.75 0 (0%)

7.75

+0.02 (+0.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07
Earnings (Next)11-11
Inst Owners88.43%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner ChangeN/A
Market Cap623.41M
Revenue(TTM)137.36M
Net Income(TTM)-885.00K
Analysts48.89
Price Target7.91 (2.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.22%
Min EPS beat(2)100%
Max EPS beat(2)276.44%
EPS beat(4)4
Avg EPS beat(4)104.9%
Min EPS beat(4)1.96%
Max EPS beat(4)276.44%
EPS beat(8)8
Avg EPS beat(8)102.34%
EPS beat(12)11
Avg EPS beat(12)79.64%
EPS beat(16)14
Avg EPS beat(16)64.19%
Revenue beat(2)2
Avg Revenue beat(2)10.95%
Min Revenue beat(2)9%
Max Revenue beat(2)12.91%
Revenue beat(4)2
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)12.91%
Revenue beat(8)6
Avg Revenue beat(8)3.99%
Revenue beat(12)7
Avg Revenue beat(12)1.42%
Revenue beat(16)10
Avg Revenue beat(16)2.44%
PT rev (1m)0%
PT rev (3m)6.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-300.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-188.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.61
P/S 4.54
P/FCF N/A
P/OCF 129.71
P/B 7.58
P/tB 17.88
EV/EBITDA 96.91
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY0.97%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.06
OCFY0.77%
SpS1.71
BVpS1.02
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROCE 0.24%
ROIC 0.19%
ROICexc 0.21%
ROICexgc 0.48%
OM 0.16%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.25
Cap/Depr 84.63%
Cap/Sales 3.82%
Interest Coverage 0.27
Cash Conversion 74.84%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 13.67
F-Score6
WACC9.27%
ROIC/WACC0.02
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y104.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.29%
EBIT Next 3Y72.41%
EBIT Next 5YN/A
FCF growth 1Y-183.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.31%
OCF growth 3Y88.66%
OCF growth 5YN/A

PERFORMANT HEALTHCARE INC / PHLT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PERFORMANT HEALTHCARE INC (PHLT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PHLT.


What is the valuation status for PHLT stock?

ChartMill assigns a valuation rating of 1 / 10 to PERFORMANT HEALTHCARE INC (PHLT). This can be considered as Overvalued.


Can you provide the profitability details for PERFORMANT HEALTHCARE INC?

PERFORMANT HEALTHCARE INC (PHLT) has a profitability rating of 1 / 10.


Can you provide the financial health for PHLT stock?

The financial health rating of PERFORMANT HEALTHCARE INC (PHLT) is 6 / 10.